168 related articles for article (PubMed ID: 36848199)
1. Pharmacodynamic and immunological interactions of amphotericin B formulations and voriconazole with human neutrophils against mature Scedosporium apiospermum and Fusarium spp. biofilms.
Vikelouda K; Simitsopoulou M; Antachopoulos C; Skoura L; Roilides E
J Antimicrob Chemother; 2023 Apr; 78(4):1076-1083. PubMed ID: 36848199
[TBL] [Abstract][Full Text] [Related]
2. Activity of Amphotericin B Formulations and Voriconazole, Alone or in Combination, against Biofilms of
Vikelouda K; Simitsopoulou M; Skoura L; Antachopoulos C; Roilides E
Antimicrob Agents Chemother; 2021 Oct; 65(11):e0063821. PubMed ID: 34370583
[No Abstract] [Full Text] [Related]
3. Amphotericin B lipid complex exerts additive antifungal activity in combination with polymorphonuclear leucocytes against Scedosporium prolificans and Scedosporium apiospermum.
Gil-Lamaignere C; Roilides E; Maloukou A; Georgopoulou I; Petrikkos G; Walsh TJ
J Antimicrob Chemother; 2002 Dec; 50(6):1027-30. PubMed ID: 12461027
[TBL] [Abstract][Full Text] [Related]
4. Antifungal triazoles and polymorphonuclear leukocytes synergize to cause increased hyphal damage to Scedosporium prolificans and Scedosporium apiospermum.
Gil-Lamaignere C; Roilides E; Mosquera J; Maloukou A; Walsh TJ
Antimicrob Agents Chemother; 2002 Jul; 46(7):2234-7. PubMed ID: 12069979
[TBL] [Abstract][Full Text] [Related]
5. Amphotericin B formulations variably enhance antifungal activity of human neutrophils and monocytes against Fusarium solani: comparison with Aspergillus fumigatus.
Dotis J; Simitsopoulou M; Dalakiouridou M; Konstantinou T; Panteliadis C; Walsh TJ; Roilides E
J Antimicrob Chemother; 2008 Apr; 61(4):810-7. PubMed ID: 18272514
[TBL] [Abstract][Full Text] [Related]
6. In vitro pharmacodynamics of amphotericin B, itraconazole, and voriconazole against Aspergillus, Fusarium, and Scedosporium spp.
Lewis RE; Wiederhold NP; Klepser ME
Antimicrob Agents Chemother; 2005 Mar; 49(3):945-51. PubMed ID: 15728887
[TBL] [Abstract][Full Text] [Related]
7. Decoding the antifungal resistance mechanisms in biofilms of emerging, ubiquitous and multidrug-resistant species belonging to the Scedosporium/Lomentospora genera.
Mello TP; Oliveira SSC; Branquinha MH; Santos ALS
Med Mycol; 2022 Jun; 60(6):. PubMed ID: 35641191
[TBL] [Abstract][Full Text] [Related]
8. Efflux pump inhibition controls growth and enhances antifungal susceptibility of
A Cordeiro R; Portela FV; Pereira LM; de Andrade AR; de Sousa JK; Aguiar AL; Pergentino ML; de Sales GS; de Oliveira JS; Medrano DJ; Brilhante RS; Rocha MF; Scm Castelo-Branco D; Sidrim JJ
Future Microbiol; 2020 Jan; 15():9-20. PubMed ID: 32043371
[No Abstract] [Full Text] [Related]
9. In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi.
Johnson EM; Szekely A; Warnock DW
J Antimicrob Chemother; 1998 Dec; 42(6):741-5. PubMed ID: 10052897
[TBL] [Abstract][Full Text] [Related]
10. Human phagocytic cell responses to Scedosporium apiospermum (Pseudallescheria boydii): variable susceptibility to oxidative injury.
Gil-Lamaignere C; Roilides E; Lyman CA; Simitsopoulou M; Stergiopoulou T; Maloukou A; Walsh TJ
Infect Immun; 2003 Nov; 71(11):6472-8. PubMed ID: 14573669
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of anidulafungin in combination with amphotericin B or voriconazole against biofilms of five Candida species.
Valentín A; Cantón E; Pemán J; Fernandez-Rivero ME; Tormo-Mas MA; Martínez JP
J Antimicrob Chemother; 2016 Dec; 71(12):3449-3452. PubMed ID: 27543657
[TBL] [Abstract][Full Text] [Related]
12. Characterization of fusarium keratitis outbreak isolates: contribution of biofilms to antimicrobial resistance and pathogenesis.
Mukherjee PK; Chandra J; Yu C; Sun Y; Pearlman E; Ghannoum MA
Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4450-7. PubMed ID: 22669723
[TBL] [Abstract][Full Text] [Related]
13. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.
Espinel-Ingroff A
J Clin Microbiol; 2001 Mar; 39(3):954-8. PubMed ID: 11230410
[TBL] [Abstract][Full Text] [Related]
14. Effects of interleukin-15 on antifungal responses of human polymorphonuclear leukocytes against Fusarium spp. and Scedosporium spp.
Winn RM; Gil-Lamaignere C; Roilides E; Simitsopoulou M; Lyman CA; Maloukou A; Walsh TJ
Cytokine; 2005 Jul; 31(1):1-8. PubMed ID: 15935692
[TBL] [Abstract][Full Text] [Related]
15. Antifungal activity of amphotericin B and voriconazole against the biofilms and biofilm-dispersed cells of Candida albicans employing a newly developed in vitro pharmacokinetic model.
El-Azizi M; Farag N; Khardori N
Ann Clin Microbiol Antimicrob; 2015 Apr; 14():21. PubMed ID: 25885806
[TBL] [Abstract][Full Text] [Related]
16. Changing epidemiology of rare mould infections: implications for therapy.
Malani AN; Kauffman CA
Drugs; 2007; 67(13):1803-12. PubMed ID: 17722951
[TBL] [Abstract][Full Text] [Related]
17. Activity of MSI-78, h-Lf1-11 and cecropin B antimicrobial peptides alone and in combination with voriconazole and amphotericin B against clinical isolates of Fusarium solani.
Denardi LB; Weiblen C; Ianiski LB; Stibbe PC; Santurio JM
J Mycol Med; 2021 Jun; 31(2):101119. PubMed ID: 33626413
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the expanding spectrum of sertraline against uncommon fungal pathogens.
Villanueva-Lozano H; González GM; Espinosa-Mora JE; Bodden-Mendoza BA; Andrade A; Martínez-Reséndez MF; Treviño-Rangel RJ
J Infect Chemother; 2020 Mar; 26(3):309-311. PubMed ID: 31678053
[TBL] [Abstract][Full Text] [Related]
19. In vitro antifungal activities of isavuconazole (BAL4815), voriconazole, and fluconazole against 1,007 isolates of zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium species.
Guinea J; Peláez T; Recio S; Torres-Narbona M; Bouza E
Antimicrob Agents Chemother; 2008 Apr; 52(4):1396-400. PubMed ID: 18212101
[TBL] [Abstract][Full Text] [Related]
20. Favorable Outcomes of Filamentous Fungal Endophthalmitis Following Aggressive Management.
Bui DK; Carvounis PE
J Ocul Pharmacol Ther; 2016 Nov; 32(9):623-630. PubMed ID: 27447804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
